1999 to 2019 Saw Increase in Substance Use+CVD-Related Mortality

2024-01-11
AHA会议临床研究
THURSDAY, Jan. 11, 2024 -- From 1999 to 2019, there was an increase in mortality related to substance use (SU) plus cardiovascular disease (CVD), according to a study published online Jan. 10 in the Journal of the American Heart Association.
Abdul Mannan Khan Minhas, M.D., from the University of Mississippi Medical Center in Jackson, and colleagues identified SU+CVD-related deaths using Multiple Cause-of-Death Public Use record death certificates and examined trends in mortality.
There were 636,572 SU+CVD-related deaths between 1999 and 2019. The researchers found the age-adjusted mortality rates were pronounced in men, in American Indian or Alaska Native individuals, in nonmetropolitan/rural areas, and for alcohol-related deaths (22.5, 37.7, 15.2, and 9.09 per 100,000 population, respectively). From 1999 to 2019, there was an increase observed in overall SU+CVD-related age-adjusted mortality rates from 9.9 to 21.4, with an average annual percent change of 4.0. Across all subgroups, there were increases seen in SU+CVD-related average annual percent changes, which were pronounced among women (4.8 percent) and for American Indian or Alaska Native individuals, younger individuals, nonmetropolitan areas, and cannabis and psychostimulant users.
"We would like to see additional public health efforts to support comprehensive evaluation and management of substance use in the U.S. that includes clinician and patient education, as well as attention to socioeconomic factors that contribute to substance use," senior author Dmitry Abramov, M.D., from the Loma Linda University Medical Center in California, said in a statement.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。